Skip to main content
. 2015 Sep 25;10(9):e0139017. doi: 10.1371/journal.pone.0139017

Fig 4. Forest plot of comparison: 1) HIV status, outcome of ADR. 1.2) ADR by region.

Fig 4

Only 8/10 studies which examined HIV as a risk factor for ADR were included as we were unable to obtain the exact proportion of those HIV seropositive among the patients that developed ADR from either the paper or by contacting the authors in the other 2 studies. The end point for 5 studies was acquisition of isoniazid/rifamycin/multidrug resistance [13,14,21,30,33] and the end point for 3 studies was acquisition of rifamycin resistance [22,28,35], based on data available.